Form 4: Rapid Micro Biosystems COO Sells Shares for Tax

Rapid Micro Biosystems' Chief Operating Officer, John J. Addington Wilson, sold 4,610 shares of Class A Common Stock to cover tax obligations related to restricted stock unit vesting.

Summary

• John J. Addington Wilson, Chief Operating Officer of Rapid Micro Biosystems, Inc. (RPID), reported a transaction on February 9, 2026.
• The transaction involved the sale of 4,610 shares of Class A Common Stock at a price of $3.7827 per share.
• This sale was an automatic transaction to cover tax obligations associated with the vesting of restricted stock units.
• Following this transaction, Mr. Wilson beneficially owns 257,768 shares of Class A Common Stock directly.
• The reported beneficial ownership includes 29,904 shares acquired under the Rapid Micro Biosystems, Inc. employee stock purchase plan on March 14, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary sale to cover tax liabilities associated with RSU vesting, which does not typically reflect a change in the insider's view of the company's fundamentals.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings detailing sales, are common for executives managing their equity compensation. Automatic sales to cover tax obligations upon RSU vesting are a routine event and typically do not signal a change in management's confidence in the company's prospects, unlike discretionary sales.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but generally not seen as a negative signal due to the tax-related nature of the sale.
• Employees: The vesting of restricted stock units and participation in an employee stock purchase plan (as noted in the beneficial ownership) indicates ongoing employee equity compensation programs.

Key Dates

Recommendation

This Form 4 details a routine, non-discretionary sale of shares by a Chief Operating Officer to cover tax obligations related to restricted stock unit vesting. Such transactions are common and do not typically provide new fundamental information about the company's operational performance or future prospects. Therefore, a seasoned investor would likely maintain their current position, as this event does not warrant a change in investment strategy.

Keywords

Rapid Micro Biosystems, RPID, Insider Trading, Form 4, Stock Sale, COO, Restricted Stock Units, Tax Obligations, Biotechnology, Medical Devices